Fulgent Genetics, Inc. FLGT Laboratory Services — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s laboratory services — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s laboratory services — operating income?
- Fulgent Genetics, Inc. (FLGT) reported laboratory services — operating income of -$15.22M in Q1 2026.
- How has Fulgent Genetics, Inc.'s laboratory services — operating income changed year-over-year?
- Fulgent Genetics, Inc.'s laboratory services — operating income decreased by 406.6% year-over-year, from -$3M to -$15.22M.
- What is the long-term trend for Fulgent Genetics, Inc.'s laboratory services — operating income?
- Over 2 years (2021 to 2025), Fulgent Genetics, Inc.'s laboratory services — operating income has grown at a -89.5% compound annual growth rate (CAGR), from $675.95M to -$7.51M.
- What does laboratory services — operating income mean?
- This is the profit or loss generated by the laboratory services segment after deducting operating expenses from total segment revenue. It provides a clear view of the core operational profitability of the laboratory business, excluding non-operating items like interest and taxes.